This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00023736%3A_____%2F00%3A00000038%21RIV%2F2001%2FMZ0%2FL33001%2FN/
n13http://linked.opendata.cz/ontology/domain/vavai/
n14http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n5http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00023736%3A_____%2F00%3A00000038%21RIV%2F2001%2FMZ0%2FL33001%2FN
rdf:type
skos:Concept n13:Vysledek
dcterms:description
High-dose immunoablative chemotherapy with autologous haematopoietic cell support might be beneficial in the treatment of intractable forms of MS. We mobilisedPBPC in 11 patients with secondary progressive MS and finally eight patients were grafted afterhigh-dose BEAM chemotherapy with either in vitro or in vivo T celldepletion. High-dose immunoablative chemotherapy with autologous haematopoietic cell support might be beneficial in the treatment of intractable forms of MS. We mobilisedPBPC in 11 patients with secondary progressive MS and finally eight patients were grafted afterhigh-dose BEAM chemotherapy with either in vitro or in vivo T celldepletion.
dcterms:title
High-dose immunosuppresive therapy with PBPC support in the treatment of poor risk multiple sclerosis. High-dose immunosuppresive therapy with PBPC support in the treatment of poor risk multiple sclerosis.
skos:prefLabel
High-dose immunosuppresive therapy with PBPC support in the treatment of poor risk multiple sclerosis. High-dose immunosuppresive therapy with PBPC support in the treatment of poor risk multiple sclerosis.
skos:notation
RIV/00023736:_____/00:00000038!RIV/2001/MZ0/L33001/N
n3:strany
521
n3:aktivita
n12:Z
n3:aktivity
Z(MZ00237360001)
n3:cisloPeriodika
5
n3:dodaniDat
n5:2001
n3:domaciTvurceVysledku
Vodvářková, Šárka Kobylka, Petr
n3:druhVysledku
n4:J
n3:duvernostUdaju
n7:S
n3:entitaPredkladatele
n6:predkladatel
n3:idSjednocenehoVysledku
712411
n3:idVysledku
RIV/00023736:_____/00:00000038
n3:jazykVysledku
n15:eng
n3:kodStatuVydavatele
VE - Bolívarovská republika Venezuela
n3:kontrolniKodProRIV
[B69741D74F53]
n3:nazevZdroje
Bone Marrow Transplantation
n3:obor
n10:FD
n3:pocetDomacichTvurcuVysledku
2
n3:pocetTvurcuVysledku
9
n3:rokUplatneniVysledku
n5:2000
n3:svazekPeriodika
25
n3:tvurceVysledku
Kobylka, Petr Havrdová, E. Piťha, J. Kozák, T. Maaloufová, J. Vodvářková, Šárka Gregora, E. Pytlík, R. Marečková, H.
n3:zamer
n14:MZ00237360001
s:issn
0268-3369
s:numberOfPages
12